Matinas BioPharma Holdings Inc at Barclays Global Healthcare Conference (Virtual) Transcript
Good afternoon, everyone. My name is Balaji Prasad. I'm the spec pharma analyst for Barclays. And continuing on with our Global Healthcare Conference on the spec pharma track for the last meeting of the day -- of today, I'm pleased to introduce you to Jerry Jabbour, President and CEO of Matinas BioPharma. There's -- the format is going to be a presentation from Jerry's side. And so with that, Jerry, I invite you to take over.
Great. Balaji, thank you very much. We're so grateful for the opportunity to present today at the Barclays Conference. We're happy to be the last meeting of the day. We know it's been a long day for investors. But we're thrilled for this to have the opportunity to present on this platform. It's been an exciting beginning to 2021 for us, and we believe the invitation to speak at the Barclays Global Healthcare Conference is really indicative of the progress we've made as a company.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |